Literature DB >> 2339901

Immunological comparison of patients with rheumatoid arthritis with and without nephropathy.

M Korpela1, J Mustonen, H Helin, A Pasternack.   

Abstract

Serum immunoglobulins IgG, IgA, and IgM, serum complement components C3 and C4, circulating immune complexes, antinuclear antibodies, and rheumatoid factor were measured in 56 patients with rheumatoid arthritis (RA) and nephropathy (23 with mesangial glomerulopathy; 13 with membranous glomerulonephritis; and 20 with amyloidosis) and 35 patients with RA without nephropathy (controls). Renal immunofluorescence findings in patients with mesangial glomerulopathy were compared with the serologic data. There were no differences in the occurrence of rheumatoid factor, antinuclear antibodies, and circulating immune complexes and the concentrations of serum complement C3 and C4 between various RA nephropathy groups and controls. Serum IgA and IgM concentrations were significantly higher in patients with mesangial glomerulopathy and amyloidosis than in controls. In patients with mesangial glomerulopathy glomerular IgM, IgA, and C3 were the most prominent findings in immunofluorescence examination. The serum IgA concentration was significantly higher in those patients with mesangial glomerulopathy with mesangial IgA deposits than in those without (4.97 (SD 1.03) g/l v 2.07 (1.21) g/l). The highest serum IgA concentrations (5.08 (1.39) g/l) were seen in the four patients with IgA glomerulonephritis. The prevalence of IgA glomerulonephritis in the renal biopsy material of the patients with RA was 5%, which possibly differs little from that seen in the general population. The results suggest that circulating immune complexes may not have any major role in the pathogenesis of various nephropathy types in patients with RA, contrary to their role in most extra-articular manifestations of RA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339901      PMCID: PMC1004040          DOI: 10.1136/ard.49.4.214

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Occurrence of mesangial IgA and IgM deposits in a control necropsy population.

Authors:  R Sinniah
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

2.  Porcine C1q and the solid-phase immunoassay of human immune complexes.

Authors:  B Ziola; A Salmi; K Penttinen
Journal:  J Immunol Methods       Date:  1982-03-26       Impact factor: 2.303

3.  Strong association of HLA-DR4 with benign IgA nephropathy.

Authors:  Y Hiki; Y Kobayashi; S Tateno; M Sada; N Kashiwagi
Journal:  Nephron       Date:  1982       Impact factor: 2.847

4.  Serum IgA and gold-induced toxic effects in patients with rheumatoid arthritis.

Authors:  P L Van Riel; L B van de Putte; F W Gribnau; R M de Waal
Journal:  Arch Intern Med       Date:  1984-07

5.  Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis.

Authors:  J Mustonen; A Pasternack; H Helin; M Nikkilä
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754

6.  Renal biopsy appearances in rheumatoid disease.

Authors:  L Sellars; K Siamopoulos; R Wilkinson; T Leohapand; A R Morley
Journal:  Clin Nephrol       Date:  1983-09       Impact factor: 0.975

7.  Circulating immune complexes in rheumatoid arthritis with extra-articular manifestations.

Authors:  H Jans; P Halberg; I Lorenzen
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

8.  Haematuria in rheumatoid arthritis: an association with mesangial glomerulonephritis.

Authors:  L D Hordon; L Sellars; A R Morley; R Wilkinson; M Thompson; I D Griffiths
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

9.  IgM-associated glomerulonephritis.

Authors:  H Helin; J Mustonen; A Pasternack; J Antonen
Journal:  Nephron       Date:  1982       Impact factor: 2.847

10.  Strong association between IgA nephropathy and HLA-DR4 antigen.

Authors:  H Kashiwabara; H Shishido; S Tomura; H Tuchida; T Miyajima
Journal:  Kidney Int       Date:  1982-10       Impact factor: 10.612

View more
  4 in total

1.  Role of amyloidosis in determining the prognosis of dialyzed patients with rheumatoid arthritis.

Authors:  Toru Sanai; Fumio Nanishi; Masatoshi Nagata; Tadashi Hirano; Eiichi Suematsu; Yukio Esaki; Hisaaki Miyahara; Mitsuo Iida
Journal:  Rheumatol Int       Date:  2006-09-30       Impact factor: 2.631

2.  Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Nakano; M Ueno; S Nishi; S Suzuki; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 3.  New advances in renal amyloidosis.

Authors:  Shinichi Nishi; Bassam Alchi; Nofumi Imai; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

4.  Variation in the serum IgA concentration and the production of IgA in vitro in rheumatoid arthritis treated by sulfasalazine.

Authors:  C Jorgensen; C Bologna; J M Anaya; T Reme; J Sany
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.